Moderna Inc (MRNA)
125.65
+14.19
(+12.73%)
USD |
NASDAQ |
May 02, 16:00
123.00
-2.65
(-2.11%)
After-Hours: 20:00
Moderna Total Return Level: 111.46 for May 1, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 01, 2024 | 111.46 |
April 30, 2024 | 110.31 |
April 29, 2024 | 111.62 |
April 26, 2024 | 107.97 |
April 25, 2024 | 106.18 |
April 24, 2024 | 108.85 |
April 23, 2024 | 107.89 |
April 22, 2024 | 104.46 |
April 19, 2024 | 101.41 |
April 18, 2024 | 102.00 |
April 17, 2024 | 103.44 |
April 16, 2024 | 103.79 |
April 15, 2024 | 103.86 |
April 12, 2024 | 105.14 |
April 11, 2024 | 107.01 |
April 10, 2024 | 107.14 |
April 09, 2024 | 111.60 |
April 08, 2024 | 105.09 |
April 05, 2024 | 102.88 |
April 04, 2024 | 102.27 |
April 03, 2024 | 101.21 |
April 02, 2024 | 103.61 |
April 01, 2024 | 105.60 |
March 28, 2024 | 106.56 |
March 27, 2024 | 110.59 |
Date | Value |
---|---|
March 26, 2024 | 107.41 |
March 25, 2024 | 110.38 |
March 22, 2024 | 105.43 |
March 21, 2024 | 104.09 |
March 20, 2024 | 103.08 |
March 19, 2024 | 105.11 |
March 18, 2024 | 104.26 |
March 15, 2024 | 103.85 |
March 14, 2024 | 103.46 |
March 13, 2024 | 106.51 |
March 12, 2024 | 110.43 |
March 11, 2024 | 111.98 |
March 08, 2024 | 103.03 |
March 07, 2024 | 99.48 |
March 06, 2024 | 98.10 |
March 05, 2024 | 95.56 |
March 04, 2024 | 96.00 |
March 01, 2024 | 95.06 |
February 29, 2024 | 92.24 |
February 28, 2024 | 97.48 |
February 27, 2024 | 96.20 |
February 26, 2024 | 94.02 |
February 23, 2024 | 96.46 |
February 22, 2024 | 99.44 |
February 21, 2024 | 87.59 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
12.26
Minimum
Aug 05 2019
484.47
Maximum
Aug 09 2021
127.04
Average
122.80
Median
Total Return Level Benchmarks
Eli Lilly and Co | 2235.83 |
Merck & Co Inc | 432.71 |
Pfizer Inc | 92.89 |
Johnson & Johnson | 485.47 |
Novavax Inc | 4.66 |